Literature DB >> 12392457

Percutaneous tracheostomy with the Blue Rhino trade mark technique: presentation of 100 consecutive patients.

B G Fikkers1, I S Briedé, J M M Verwiel, F J A Van Den Hoogen.   

Abstract

We assessed the peri-operative, early and late complications in 100 percutaneous tracheostomies performed with the Blue Rhino trade mark kit. The success rate was 98%. Peri-operative complications occurred in 30 patients. Six major complications occurred; these included bleeding which required surgical exploration (n = 3), and pneumothoraces (n = 2) and one false passage. Cannula insertion was made easier by blunt dissection of the cervical tissues anterior to the trachea. The median duration of the procedure was 8.5 min, which is significantly longer than other authors' results. Only one major complication occurred while the patient was cannulated (serious bleeding requiring exploration). Finally, in a single patient a tracheal stenosis occurred as a major late complication which eventually was treated by a successful tracheal resection. Percutaneous tracheostomy with the Blue Rhino trade mark kit is safe with a low incidence of major complications.

Entities:  

Mesh:

Year:  2002        PMID: 12392457     DOI: 10.1046/j.1365-2044.2002.02834.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  13 in total

1.  Perforation of the trachea by an endotracheal tube: an autopsy case.

Authors:  Hiroaki Sato; Toshiko Tanaka; Kentaro Kasai; Toshiro Kita; Noriyuki Tanaka
Journal:  Int J Legal Med       Date:  2008-11-19       Impact factor: 2.686

2.  Naushad's Modification of Griggs Percutaneous Tracheostomy: Retrospective Case Series Study on 200 Patients at Subharti Medical College, Meerut, India.

Authors:  Omar Naushad; M Bashir; Sonal Rathee
Journal:  Maedica (Bucur)       Date:  2022-03

3.  Percutaneous dilatational tracheostomies in a newly established trauma center: a report from Qatar.

Authors:  A Parchani; R Peralta; A El-Menyar; M Tuma; A Zarour; S Kumar; H Abdulrahman; Y AbdulRahman; H Al-Thani; R Latifi
Journal:  Eur J Trauma Emerg Surg       Date:  2013-06-08       Impact factor: 3.693

4.  Early and late outcome after single step dilatational tracheostomy versus the guide wire dilating forceps technique: a prospective randomized clinical trial.

Authors:  Bernard G Fikkers; Marieke Staatsen; Frank J A van den Hoogen; Johannes G van der Hoeven
Journal:  Intensive Care Med       Date:  2011-04-12       Impact factor: 17.440

5.  Bilateral pneumothoraces, pneumomediastinum, pneumoperitoneum, pneumoretroperitoneum, and subcutaneous emphysema after percutaneous tracheostomy -A case report-.

Authors:  Won Ho Kim; Byoung Ho Kim
Journal:  Korean J Anesthesiol       Date:  2012-05-24

6.  Percutaneous dilatation tracheostomy: which technique is the best for the critically ill patient, and how can we gather further scientific evidence?

Authors:  Ansgar Brambrink
Journal:  Crit Care       Date:  2004-09-08       Impact factor: 9.097

7.  Case of difficult tracheostomy tube insertion: A novel yet simple solution to the dilemma.

Authors:  Hemani Ahuja; Ashu S Mathai; Reetika Chander; Amy E Mathew
Journal:  Anesth Essays Res       Date:  2013 Sep-Dec

8.  Percutaneous dilatational tracheostomy: Griggs guide wire dilating forceps technique versus ULTRA-perc single-stage dilator - A prospective randomized study.

Authors:  Mritunjay Kumar; Anjan Trikha
Journal:  Indian J Crit Care Med       Date:  2012-04

9.  Acute upper airway failure and mediastinal emphysema following a wire-guided percutaneous cricothyrotomy in a patient with severe maxillofacial trauma.

Authors:  R Barkhuysen; M A W Merkx; P A van Damme; O R Buyne; F J A van den Hoogen
Journal:  Oral Maxillofac Surg       Date:  2008-05

10.  Comparison of two percutaneous tracheostomy techniques, guide wire dilating forceps and Ciaglia Blue Rhino: a sequential cohort study.

Authors:  Bernard G Fikkers; Marieke Staatsen; Sabine G G F Lardenoije; Frank J A van den Hoogen; Johannes G van der Hoeven
Journal:  Crit Care       Date:  2004-07-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.